Results 91 to 100 of about 1,479 (165)

Atividade anti-tumoral do composto LaSOM 65, derivado do monastrol, em linhagens de gliomas [PDF]

open access: yes, 2011
Os gliomas são os tumores primários mais comuns no sistema nervoso central. Apesar dos progressos recentes no tratamento do glioblastoma, a sobrevida média dos pacientes ainda permanece em 15 meses.
Cristiane dos Santos Stuepp   +1 more
core  

Abstracts

open access: yes
Molecular Oncology, Volume 18, Issue S1, Page 1-495, June 2024.
wiley   +1 more source

Elevated expression of survivin induces mitotic arrest and increases cell viability in the presence of monastrol.

open access: yes, 2015
(A–D) AGS cells were stably transfected with a plasmid expressing GFP (vector) or a plasmid that encodes for overexpression of survivin-GFP (pSurvivin). Cells were treated with 100μM monastrol and processed for microtubule immunostaining (A and B), cell ...
Michal Hershfinkel (303795)   +3 more
core   +1 more source

Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani

open access: yes, 2010
Objectives: Using the pteridine reductase (PTR1) enzyme of Leishmania as the target, the objective of our study was to find a drug candidate that can enter the clinical development process after being evaluated for safety and efficacy in animals. Methods:
Neeloo Singh   +5 more
core   +1 more source

Design and discovery of novel monastrol-1,3,5-triazines as potent anti-breast cancer agent via attenuating Epidermal Growth Factor Receptor tyrosine kinase

open access: yesScientific Reports, 2017
A novel series of hybrid analogues of monastrol-1,3,5-triazine were designed and developed via one-pot synthesis using Bi(NO3)3 as a catalyst. Entire compounds were evaluated for their anticancer activity against HeLa (cervical cancer), MCF-7 (breast ...
Jitendra Kumar Srivastava   +4 more
doaj   +1 more source

Híbrido de monastrol-H2S : síntese e atividade antiproliferativa contra células de câncer de ovário

open access: yes, 2015
Cancer represents one of the mayor causes of death in the world. According to OMS, this illness has been responsible for 8,2 million deaths in 2012, mainly due to the absence of efficient methods and drugs for treatment.
Taniris Cafiero Braga
core  

Cytotoxic monastrol derivatives as adjective inhibitors of drug-resistant Eg5: a molecular dynamics perspective

open access: yes
The mitotic kinesin Eg5 is a motor protein involved in the formation of bipolar spindle and cell division. Eg5 is overexpressed in various cancer cells and Eg5 targeting agents are promising candidates for cancer therapy.
N. Razzaghi-Asl (18119229)   +2 more
core   +1 more source

Structure of human Eg5 in complex with a new monastrol-based inhibitor bound in the R configuration

open access: yes, 2007
Drugs that target mitotic spindle proteins have been proven useful for tackling tumor growth. Eg5, a kinesin-5 family member, represents a potential target, since its inhibition leads to prolonged mitotic arrest through the activation of the mitotic ...
DeBonis, S   +6 more
core   +1 more source

Positive allosteric modulation of the GHB high-affinity binding site by the GABAA receptor modulator monastrol and the flavonoid catechin

open access: yes, 2014
γ-Hydroxybutyric acid (GHB) is a metabolite of γ-aminobutyric acid (GABA) and a proposed neurotransmitter in the mammalian brain. We recently identified α4βδ GABAA receptors as possible high-affinity GHB targets.
Higgins, David   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy